Forecast & RatingOnly 1 analyst currently covers COSCIENS BIOPHARMA INC (CSCID.US), with a price target of $180.00 and a rating of "Overweight". The sample is very small, so treat this as a reference only. Data as of Jul 8, 2026; this does not constitute investment advice.
Nov 13, 2023Price forecast
$180.003401.93%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateJul 26, 2026
Forecast met0.0%
Stock price$5.14
Avg. target$180.0
High target$180
Low target$180
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.